| INTRODUCTION
Influenza viruses circulate every year, causing epidemics that are usually benign and mild for the human population but that can complicate into other diseases, like pneumonia. According to Wuerth et al (2016) , 1 in the 2002-2011 period, influenza was the fourth causative agent for pneumonia and approximately 9/100 000 of pneumonia hospitalizations had influenza as the etiological respiratory agent. However, as influenza laboratory diagnosis is not usually performed in all suspected cases, using these data underestimate the influenza impact. 2, 3 Taking this into consideration, the overall effect of influenza epidemics has been measured through indirect ecologic methods using the Serfling approach 4 and Poisson, negative binomial regression and autoregressive integrated moving average (ARIMA) models to estimate influenzaassociated mortality or hospitalizations rates. [5] [6] [7] [8] [9] There are two main approaches in estimating influenza-associated excesses: one based on statistical models that include influenza activity indicators as explanatory covariates; another does not consider covariates and by excluding from the estimating process all parts of the outcome time series where there is evidence of occurrence of some event that might influence the outcome. 9 Both approaches have pros and cons. Using models with covariates allows estimating influenza-associated outcomes by virus type and subtype, but requires robust virological data. 10 In the alternative, this specific data requirement is not needed and can be used provided that consistent mortality or hospitalization time series are available. 10 However, there are limitations also in this approach.
The lack of virological covariates in the model implies the assumption that all excess winter mortality is associated with influenza circulation which may not be appropriate, leading therefore to a mortality overestimation.
The identification of influenza epidemics requires influenza surveillance data, with information on influenza virus type, and influenza epidemic activity period. 11, 12 Also, and when available, the identification of other events that contribute to mortality or hospitalizations distribution, like secular trend or seasonality, is desirable so to get a better fit of the model to the time series and improve the quality and the validity of the influenza attributable excess estimate. 13 The influenza impact is particularly evident in specific groups, like the elderly, pregnant and those with chronic disease, with higher risk of complications associated with influenza infection leading to hospitalization or death. 14 For this high-risk group of individuals, yearly vaccination in the autumn is recommended in Portugal and in most EU countries, with the intention of reducing risk of complications, severe disease, and death. 15, 16 The influenza vaccine has proven to be moderately effective in reducing medically attended confirmed influenza. 17 Using an ecologic approach, one would expect a reduction in excess hospitalizations/mortality with increasing vaccine coverage and this was already reported in previous influenza-related outcomes studies. 18, 19 In Portugal, there are several studies that associate this respiratory infection with excess pneumonia and influenza (P&I) and all-causes mortality. 8, 13 However, information on influenza impact on morbidity indicators, such as hospital admissions, is scarce and the knowledge of influenza impact and the role of immunization on hospitalizations is essential for a better resource management and for preparing mitigation measures. 
| METHODS
A time series ecological study was conducted to estimate the baseline of weekly P&I hospitalizations free of influenza epidemics and estimate excess P&I hospitalizations associated with influenza epidemics between 1998/1999 and 2014/2015 seasons.
| Hospital discharge data
Weekly hospitalizations with P&I as principal diagnosis, according to the International Classification of Disease (ICD 9: 480-487), were extracted from the National Hospital Discharge database (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) .
Weekly time series were disaggregated by age group: <2, 2-4, 5-14, 15-49, 50-64, and 65 and more years.
| Influenza activity
The definition of influenza epidemic periods was based on information from the Portuguese Influenza Surveillance System. by National Influenza Reference Laboratory, and was defined according to Influenza Reporting Protocol. 21 The threshold for dominance was set at 60%, and the threshold for codominance is set between 40% and 60%. 
| Periods potentially associated with excess hospitalizations
These periods include the influenza epidemic (description above on Influenza activity), 2009 pandemic influenza, 22 and heat wave periods (weeks in which two or more consecutive days had an average maximum daily temperature above 32°C with an extra week to account the known delay of impact.
13,23
| Influenza vaccine coverage rates
The influenza vaccine coverage (IVC) rates, for individuals with 65 and more years, were obtained from ECOS (Em Casa Observamos Saúde-At
Home We Watch Health), a panel of approximately 1000 households on which a seasonal survey is carried out by computer-assisted telephone interview (CATI). 24 These households were selected randomly from the national telephone directory and recruited considering the representativeness of Portuguese mainland families reachable by telephone.
| Methods to estimate the number of excess hospitalization associated with influenza epidemics
Age-specific baseline hospitalization rates were estimated by ARIMA model, 25 after extracting from the time series the periods potentially associated with excess hospitalizations (defined above and presented on Table S1 ), using Flubase R package. 26 ARIMA model is composed of Using an automatic model identification algorithm included on the package, which recurs to a specific R package named forecast, the final models (Table S2) were selected. 27 Excess hospitalization rates were calculated by subtracting P&I weekly hospitalization rates baseline, obtained through the model fitting, from the observed weekly P&I hospitalization rates during influenza epidemic periods ( Figure 1 ).
Season excess P&I hospitalization rates 95% confidence level were calculated by approximation to the normal distribution, using F I G U R E 1 Weekly P&I hospitalization rate per 100 000 inhabitants and the respective estimated baseline and baseline upper limit in the absence of the impact of influenza epidemics from 1998 to 2015
as standard error the product of the square root of the number of weeks with excess mortality by the standard deviation of the model residual.
Correlation between season excess rate of hospitalizations and influenza vaccine coverage (last column of A significance level of 5% was considered. A very different distribution of the excess P&I hospitalization rate was registered for the influenza A(H1)pdm09 predominant seasons, the highest rate being observed for the <2-year age group. Considering the age group for which the vaccine is recommended (≥65 years), the lowest average excess P&I hospitalization rate, per predominant (sub)-type influenza season, was observed during the pandemic season ( Figure 4 ). Nevertheless, for the individuals with age between 5 and 64 years it was during the pandemic that the highest excess P&I hospitalization rates were observed in particular for the age group 5-49 in which the rate was 10 times the average rate for the influenza B predominant seasons. 
| RESULTS

| Overall burden of influenza epidemics
| Age-specific estimates
F I G U R E 2
| Association between influenza vaccine coverage and seasonal excess P&I influenza-associated hospitalization rates among the elderly
The overall correlation between the influenza vaccine coverage 
| DISCUSSION
The present study is the first Portuguese comprehensive analysis aimed at estimating the excess of pneumonia and influenza hospi- habitants reaching a maximum of 46.1 per 100 000 habitants. Our overall estimated P&I influenza-associated excess hospitalization rate was in the agreement with the reported estimates in other studies. 30 Overall, seasonal P&I excess hospitalization rates were higher among the individuals with <2 years and among those with 65 or more years of age. These results are compatible with those published in other studies that include these two groups at higher risk of being hospitalized during influenza seasonal epidemics. 3, 31, 32 Nevertheless, this pattern was not equal in all seasons, specifically during the pandemic A(H1)pdm09 season, where no excess P&I hospitalizations were observed among the elderly (≥65 years). On the other hand, the excess P&I hospitalization was the highest observed within the individuals aged between 2 and 65 years, a population group that, during seasonal influenza epidemics, presented the lowest influenza-associated excess P&I hospitalization rates. This observation was consistent with other European studies 30, [33] [34] [35] and with mortality profile of the pandemic A(H1)pdm09 in Portugal. 22 According to some authors, 36,37 the elderly population was largely spared during the pandemic mainly due to their past exposure to influenza virus similar to the A(H1N1)pdm09
virus and younger age groups were naive to this new circulating virus.
This fact was reflected in the recommendations issued by health authorities regarding the pandemic monovalent vaccine uptake that did not include the individuals aged 65 or more years of age.
38,39
The excess P&I hospitalizations profile was maintained in seasons also had much higher impact on the elderly age group compared to the other virus profiles. This result has been largely described in other study, 5 targeting these two age groups as the ones with the highest impact of influenza-associated hospitalizations and in particular when influenza A(H3) subtype is predominant. The previously described excess P&I mortality rate profile in Portugal 8 has showed a different profile, with small or no impact among the younger age groups contrasting with higher excess P&I mortality rate for the age groups above 65 years or more. These results are in line with an expected higher influenza lethality rate among the older age groups.
In this study, among the individuals with 65 or more years of age, variate. This study also highlighted that, in the absence of robust covariates data, namely on weekly influenza type and subtype data in specific age groups, ARIMA models are a good candidate model to be used in influenza-associated excess studies. 10 Finally, our study did not take into consideration the correlation between circulating influenza virus and vaccine strains. This could have implications on the correlation estimates between vaccine coverage and influenza-associated P&I hospitalizations.
In summary, our type/subtype and age-specific influenzaassociated P&I hospitalizations are in accordance with the literature on influenza excess hospitalization and provide for the first time a measure of the impact of influenza in Portugal for a wide period. Also, this study evidences that there is a negative correlation between influenza vaccination and the influenza-associated P&I hospitalizations, in particular when A(H3) is circulating and in the risk group of the elderly for which the vaccine is recommended. These results are encouraging, specially to validate campaigns for vaccine uptake in seasonal epidemics and in specific age groups in a future pandemic.
Nevertheless, more studies should be performed to evaluate the consistency of these results. Following this line of thought, it is important to continue researches in Portugal by looking into other hospitalizations causes and by incorporating additional information on influenza type/subtype circulation as well as other respiratory virus as a way to fortify these findings.
